aid: escient-pharmaceuticals
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/escient-pharmaceuticals.png
name: Escient Pharmaceuticals
description: 'Escient Pharmaceuticals is a San Diego, California clinical-stage biopharmaceutical company
  developing first-in-class, oral small-molecule therapeutics targeting Mas-related G protein-coupled receptors
  (MRGPRs) along the neurosensory-inflammatory axis. Its lead programs are EP262, an MRGPRX2 antagonist for
  mast-cell-mediated diseases such as chronic spontaneous and inducible urticaria and atopic dermatitis, and
  EP547, an MRGPRX4 antagonist for cholestatic and uremic pruritus. The company was backed by New Enterprise
  Associates (NEA) and was acquired by Incyte Corporation on May 30, 2024. Escient operates a corporate
  marketing website only and publishes no public API, developer program, or machine-readable API specification;
  this profile captures its identity and domain-security posture for the API Evangelist network.'
url: https://raw.githubusercontent.com/api-evangelist/escient-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- nea
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Life Sciences
- Pharmaceuticals
- Biotechnology
- Clinical Stage
- Drug Discovery
- Immunology
- Dermatology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/escient-pharmaceuticals-domain-security.yml
- type: Website
  url: https://www.escientpharma.com
- type: Blog
  url: https://www.escientpharma.com/news/
- type: Support
  url: https://www.escientpharma.com/contact/
- type: PrivacyPolicy
  url: https://www.escientpharma.com/privacy-policy/
- type: TermsOfService
  url: https://www.escientpharma.com/terms-of-use/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence